Through the API platform Sekhmet Pharmaventures, PAG, an international investment firm, along with consortium partners CX Partners and Samara Capital, purchased a controlling interest in the Hyderabad-based pharmaceutical company Optimus Group.

Optimus, a manufacturer of pharmaceutical goods with vertical integration that includes advanced intermediates, active pharmaceutical ingredients (APIs), and finished medications, was established in 2004. Presently, it exports to 40 nations more than 100 different items.

The consortium, which wants to create a best-in-class centre for discovering and producing bulk medicinal ingredients, agreed to purchase Anjan Drugs in 2020.